Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Medical Informatics and Decision Making
Published in: BMC Medical Informatics and Decision Making 1/2015

Open Access 01-12-2015 | Research article

Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)

Authors: Guendalina Graffigna, Serena Barello, Andrea Bonanomi, Edoardo Lozza, Judith Hibbard

Published in: BMC Medical Informatics and Decision Making | Issue 1/2015

Login to get access

Abstract

Background

The Patient Activation Measure (PAM13) is an instrument that assesses patient knowledge, skills, and confidence for disease self-management. This cross-sectional study was aimed to validate a culturally-adapted Italian Patient Activation Measure (PAM13-I) for patients with chronic conditions.

Methods

519 chronic patients were involved in the Italian validation study and responded to PAM13-I. The PAM 13 was translated into Italian by a standardized forward-backward translation. Data quality was assessed by mean, median, item response, missing values, floor and ceiling effects, internal consistency (Cronbach's alpha and average inter-item correlation), item-rest correlations. Rasch Model and differential item functioning assessed scale properties.

Results

Mean PAM13-I score was 66.2. Rasch analysis showed that the PAM13-I is a good measure of patient activation. The level of internal consistency was good (α = 0.88). For all items, the distribution of answers was left-skewed, with a small floor effect (range 1.7–4.5 %) and a moderate ceiling effect (range 27.6–55.0 %). The Italian version formed a unidimensional, probabilistic Guttman-like scale explaining 41 % of the variance.

Conclusion

The PAM13-I has been demonstrated to be a valid and reliable measure of patient activation and the present study suggests its applicability to the Italian-speaking chronic patient population. The measure has good psychometric properties and appears to be consistent with the developmental nature of the patient activation phenomenon, although it presents a different ranking order of the items comparing to the American version.
PAM13-I can be a useful assessment tool to evaluate interventions aimed at improving patient engagement in healthcare and to train doctors in attuning their communication to the level of patients’ activation. Future research could be conducted to further confirm the validity of the PAM13-I.
Appendix
Available only for authorised users
Literature
1.
2.
Stiggelbout AM, Van der Weijden T, De Wit MPT, Frosch D, Légaré F, Montori VM, et al. Shared decision making: really putting patients at the centre of healthcare. BMJ. 2012; doi:http://​dx.​doi.​org/​10.​1136/​bmj.​e256.
3.
Mockford C, Staniszewska S, Griffiths F, Herron-Marx S. The impact of patient and public involvement on UK NHS health care: a systematic review. Int J Qual Health Care. 2012; doi:http://​dx.​doi.​org/​10.​1093/​intqhc/​mzr066.
4.
Miles A, Mezzich J. The care of the patient and the soul of the clinic: person-centered medicine as an emergent model of modern clinical practice. Int J Pers Cent Med. 2011;1:207–22.
5.
Carman KL, Dardess P, Maurer M, Sofaer S, Adams K, Bechtel C, et al. Patient and family engagement: a framework for understanding the elements and developing interventions and policies. Health Aff. 2013; doi:10.​1377/​hlthaff.​2012.​1133.
6.
7.
Eaton S, Roberts S, Turner B. Delivering person centred care in long term conditions. BMJ. 2015; doi:http://​dx.​doi.​org/​10.​1136/​bmj.​h181.
8.
Pulvirenti M, Hons BA, McMillan J, Lawn S. Empowerment, patient centred care and self‐management. Health Expect. 2014;17:303–10.CrossRefPubMed
9.
Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is Patient Activation Associated with Outcomes of Care for Adults with Chronic Conditions? J Ambul Care Manage. 2007;30:21–9.CrossRefPubMed
10.
11.
Hibbard JH, Greene J, Overton V. Patients with lower activation associated with higher costs; delivery systems should know their patients’‘scores’. Health Aff. 2013; doi:10.​1377/​hlthaff.​2012.​1064.
12.
Graffigna G, Barello S, Wiederhold BK, Bosio AC, Riva G. Positive technology as a driver for health engagement. Stud Health Technol Inform. 2013;191:9–17.PubMed
13.
Wiederhold BK, Graffigna G, Riva G. Ensuring the best care for our increasing aging population: health engagement and positive technology can help patients achieve a more active role in future healthcare. Cyberpsychol Behav. 2013; doi:10.​3233/​978-1-61499-282-0-9.
14.
15.
Graffigna G, Barello S, Bonanomi A, Lozza E. Measuring patient engagement: development and psychometric properties of the Patient Health Engagement (PHE) scale. Front psychol. 2015; doi:10.​3389/​fpsyg.​2015.​00274.
16.
17.
18.
19.
Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Management. 2007;30:21–9.CrossRef
20.
Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med. 2012;27:520–6.CrossRefPubMed
21.
Greene J. Patient activation improves health outcomes, reduces costs. PharmacoEconomics & Outcomes News. 2015;723:22–2.
22.
23.
Stepleman L, Rutter MC, Hibbard J, Johns L, Wright D, Hughes M. Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. Disabil Rehabil. 2010; doi:10.​3109/​0963828090356788​5.
24.
Brenk-Franz K, Hibbard JH, Herrmann WJ, Freund T, Szecsenyi J, Djalali S, et al. Validation of the German version of the Patient Activation Measure 13 (PAM13-D) in an international multicentre study of primary care patients. PloS one. 2013; doi:10.​1371/​journal.​pone.​0074786.
25.
Rademakers J, Nijman J, van der Hoek L, Heijmans M, Rijken M. Measuring patient activation in the Netherlands: translation and validation of the American short form Patient Activation Measure (PAM13). BMC Public Health. 2012; doi:10.​1186/​1471-2458-12-577.
26.
Maindal HT, Sokolowski I, Vedsted P. Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version. BMC Public Health. 2009; doi:10.​1186/​1471-2458-9-209.
27.
28.
Moljord IEO, Lara-Cabrera ML, Perestelo-Pérez L, Rivero-Santana A, Eriksen L, Linaker OM. Psychometric properties of the Patient Activation Measure-13 among out-patients waiting for mental health treatment: A validation study in Norway. Patient Educ Couns. 2015; doi:10.​1016/​j.​pec.​2015.​06.​009.
29.
Ahn YH, Yi CH, Ham OK, Kim BJ. Psychometric properties of the Korean version of the “Patient Activation Measure 13” (PAM13-K) in patients with osteoarthritis. Eval Health Prof. 2015; doi:10.​1177/​0163278714540915​.
30.
Green CA, Perrin NA, Polen MR, Leo MC, Hibbard JH, Tusler M. Development of the Patient Activation Measure for mental health. Adm Policy Ment Hlth. 2010;37:327–33.CrossRef
31.
32.
Hung M, Carter M, Hayden C, Dzierzon R, Morales J, Snow L, et al. Psychometric assessment of the patient activation measure short form (PAM-13) in rural settings. Qual Life Res. 2013;22:521–9.CrossRefPubMed
33.
34.
Barello S, Graffigna G, Vegni E, Savarese M, Lombardi F, Bosio AC. ‘Engage me in taking care of my heart’: a grounded theory study on patient–cardiologist relationship in the hospital management of heart failure. BMJ open. 2015; doi:10.​1136/​bmjopen-2014-005582.
35.
Bertoni A, Donato S, Graffigna G, Barello S, Parise M. Engaged patients, engaged partnerships: singles and partners dealing with an acute cardiac event. Psychol Health Med. 2015; doi:10.​1080/​13548506.​2014.​969746.
36.
37.
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19:539–49.CrossRefPubMedPubMedCentral
38.
Clark A, Watson D. Constructing validity: basic issues in objective scale development. Psychol Assess. 1995;7:309–19.CrossRef
39.
Weinberg SL, Statistics KAS, Using SPSS. An Integrative Approach. 2nd ed. New York: Cambridge University Press; 2008.
40.
Bonanomi A, Osmetti SA. A new corruption index based on individual attitudes. IJMEF. 2013;6:232–43.CrossRef
41.
Andrich D, Sheridan B, Lyne A, Luo G. RUMM: A Windows-based Item Analysis Program Employing Rasch Unidimensional Measurement Models. Perth. WA: Murdoch University; 2000.
42.
Las Hayas C, Quintana J, Padierna J, Bilbao A, Munoz P. Use of RASCH methodology to develop a short version of the health related quality of life for eating disorders questionnaire: a prospective study. Health Qual Life Outcomes. 2010;8:29.CrossRefPubMedPubMedCentral
43.
Linacre J. Estimating measures with known polytomous item difficulties. RMT. 1998;12:638.
44.
Wright BD, Linacre JM, Gustafson JE, Martin-Lof P. Reasonable mean-square fit values. RMT. 1994;8:370.
45.
Insignia Health. Patient Activation Measure (PAM) 13™. License Materials. Portland, Oregon: Insignia Health LLC; 2011.
46.
47.
Smith AB, Rush R, Fallowfield LJ, Velikova G, Sharpe M. Rasch fit statistics and sample size considerations for polytomous data. BMC Med Res Methodol. 2008; doi:10.​1186/​1471-2288-8-33.
48.
DeVellis RF. Scale Development:Theory and Applications. 3rd ed. London: SAGE publications; 2012.
49.
Rodin J. Health, control, and aging. In: Baltes MM, Baltes PB, editors. The Psychology of Control and Aging. New York: Psychology Press; 2014. p. 139–65.
50.
51.
52.
Randers I, Mattiasson AC. Autonomy and integrity: upholding older adult patients’ dignity. J Adv Nurs. 2004;45:63–71.CrossRefPubMed
53.
Packer TL, Kephart G, Ghahari S, Audulv Å, Versnel J, Warner G. The Patient Activation Measure: a validation study in a neurological population. Qual Life Res. 2015;24:1587–96.CrossRefPubMed
54.
Alden DL, Friend JM, Lee AY, de Vries M, Osawa R, Chen Q. Culture and Medical Decision Making: Healthcare Consumer Perspectives in Japan and the United States. Health Psychol. 2015.
55.
Sturgis P. Survey and sampling. In: Breakwell GM, Hamond S, Fife-Schaw C, Smith JA, editors. Research Methods in Psychology. London: Sage; 2006. p. 104–22.
56.
57.
Rask KJ, Ziemer DC, Kohler SA, Hawley JN, Arinde FJ, Barnes C. Patient activation is associated with healthy behaviours and ease in managing diabetes in an indigenous population. Diabetes Educ. 2009; doi:10.​1177/​0145721709335004​.
58.
Montirosso R, Morandi F, D'aloisio C, Berna A, Provenzi L, Borgatti R (2009). International classification of functioning, disability and health in children with congenital central hypoventilation syndrome. Disabil Rehabil. 2009; doi:10.​3109/​0963828090331780​7
59.
Hibbard JH, Greene J, Tusler M. Improving the outcomes of disease management by tailoring care to the patient’s level of activation. J Ambul Care Manage. 2009;15:353–60.
60.
61.
62.
Barello S, Graffigna G, Meyer EC. Ethics and Etiquette in Neonatal Intensive Care: The Value of Parents’ Engagement in Everyday Ethics and Recommendations for Further Advancing the Field. JAMA pediatrics. 2015; doi:10.​1001/​jamapediatrics.​2014.​2958.
63.
Graffigna G, Vegni E, Barello S, Olson K, Bosio AC. Studying the social construction of cancer-related fatigue experience: the heuristic value of ethnoscience. Patient Educ Couns. 2011; doi:10.​1016/​j.​pec.​2010.​12.​017.
64.
Graffigna G, Barello S, Libreri C, Bosio AC. How to engage type-2 diabetic patients in their own health management: implications for clinical practice. BMC Public Health. 2014; doi:10.​1186/​1471-2458-14-648.
65.
Lamiani G, Barello S, Browning DM, Vegni E, Meyer EC. Uncovering and validating clinicians’ experiential knowledge when facing difficult conversations: A cross-cultural perspective. Patient Educ Couns. 2012; doi:10.​1016/​j.​pec.​2011.​11.​012.
66.
Metadata
Title
Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)
Authors
Guendalina Graffigna
Serena Barello
Andrea Bonanomi
Edoardo Lozza
Judith Hibbard
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2015
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-015-0232-9

Other articles of this Issue 1/2015

BMC Medical Informatics and Decision Making 1/2015 Go to the issue

Research article

Logic regression-derived algorithms for syndromic management of vaginal infections

Research Article

Surveillance of dengue vectors using spatio-temporal Bayesian modeling

Research article

Latitude-based approach for detecting aberrations of hand, foot, and mouth disease epidemics

Research article

Development and pilot feasibility study of a health information technology tool to calculate mortality risk for patients with asymptomatic carotid stenosis: the Carotid Risk Assessment Tool (CARAT)

Research article

Analysis and classification of oncology activities on the way to workflow based single source documentation in clinical information systems

Research article

A qualitative evaluation of the crucial attributes of contextual Information necessary in EHR design to support patient-centered medical home care